Choriocarcinoma (Gestational Trophoblastic Neoplasia) drugs in development, 2023

GlobalData tracks 5 drugs in development for Choriocarcinoma (Gestational Trophoblastic Neoplasia) by four companies/universities/institutes. The top development phase for Choriocarcinoma (Gestational Trophoblastic Neoplasia) is phase i, with four drugs in that stage.

Astellas Acquires Eye-Disease Specialist Iveric for Almost $6B

Credit: FG Trade/Getty Images Astellas is acquiring Iveric Bio for approximately $5.9 billion, making Iveric a wholly-owned subsidiary. The purchase price, $40.00 per share, represents

May 1, 2023

A new report questions whether digital diabetes programs are worth the cost

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Employers, insurers and investors have long been

March 27, 2024

Solriamfetol may be an effective alternative for managing ADHD in adults, trial shows

Although several medications are approved to treat attention-deficit/hyperactivity disorder (ADHD), some individuals experience limited benefits from the drugs or develop side effects from their use.

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.